Search results
8 maj 2023 · Aquapheresis has been studied as a modality for fluid removal in patients with acute decompensated heart failure who do not respond to escalating doses of diuretics. Several clinical trials have been conducted to compare the two treatment options.
10 kwi 2024 · Fortunately, remarkable scientific advances have been made in the past few years that have led to new treatments and improved prognosis for patients with heart failure. This review examines these changes with a focus on the diagnosis and medical management of heart failure.
Aquapheresis is a form of slow continuous ultrafiltration where blood is removed by applying negative pressure by the machine, which is then passed through the unique filter across which a set fraction of plasma water is filtered each minute before it is pumped back into the patient.
5 dni temu · Crafting a fine heart: steroidal and non-steroidal mineralocorticoid receptor antagonists improve outcomes in heart failure. Steroidal MRAs, such as spironolactone and eplerenone, reduce morbidity and mortality in HF with reduced ejection fraction (HFrEF) and are strongly recommended by international HF guidelines. 1, 2 However, their efficacy in HFmrEF/HFpEF remains uncertain, because results ...
1 kwi 2022 · Amyloid heart disease has new recommendations for treatment including screening for serum and urine monoclonal light chains, bone scintigraphy, genetic sequencing, tetramer stabilizer therapy, and anticoagulation.
8 maj 2023 · The primary utilization of AQ has been in the management of patients with diuretic resistant heart failure with a treatment goal directed to quickly eliminate the excess fluid and optimize...
The large-scale AVOID-HF (Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart Failure) trial compared ultrafiltration and medical treatment in acute heart failure (HF) . A major advantage of this study was the use of adjustable, rather than fixed, treatment regimens in both arms.
